Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis

Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis

Bibliographic Details
Main Authors: Jennifer Albus Fehlman, MD, Nicole M. Burkemper, MD, Tricia A. Missall, MD, PhD
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:JAAD Case Reports
Subjects:
anti–tumor necrosis factor-α inhibitors
etanercept
hydroxychloroquine
necrobiosis lipoidica
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512617300097
id doaj-2150cf2b71e1473d971ecdef6ed8e748
record_format Article
spelling doaj-2150cf2b71e1473d971ecdef6ed8e7482020-11-25T01:09:40ZengElsevierJAAD Case Reports2352-51262017-03-013212713010.1016/j.jdcr.2017.01.006Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritisJennifer Albus Fehlman, MDNicole M. Burkemper, MDTricia A. Missall, MD, PhDhttp://www.sciencedirect.com/science/article/pii/S2352512617300097anti–tumor necrosis factor-α inhibitorsetanercepthydroxychloroquinenecrobiosis lipoidica
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer Albus Fehlman, MD
Nicole M. Burkemper, MD
Tricia A. Missall, MD, PhD
spellingShingle Jennifer Albus Fehlman, MD
Nicole M. Burkemper, MD
Tricia A. Missall, MD, PhD
Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
JAAD Case Reports
anti–tumor necrosis factor-α inhibitors
etanercept
hydroxychloroquine
necrobiosis lipoidica
author_facet Jennifer Albus Fehlman, MD
Nicole M. Burkemper, MD
Tricia A. Missall, MD, PhD
author_sort Jennifer Albus Fehlman, MD
title Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
title_short Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
title_full Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
title_fullStr Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
title_full_unstemmed Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
title_sort ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
publisher Elsevier
series JAAD Case Reports
issn 2352-5126
publishDate 2017-03-01
topic anti–tumor necrosis factor-α inhibitors
etanercept
hydroxychloroquine
necrobiosis lipoidica
url http://www.sciencedirect.com/science/article/pii/S2352512617300097
work_keys_str_mv AT jenniferalbusfehlmanmd ulcerativenecrobiosislipoidicainthesettingofantitumornecrosisfactoraandhydroxychloroquinetreatmentforrheumatoidarthritis
AT nicolemburkempermd ulcerativenecrobiosislipoidicainthesettingofantitumornecrosisfactoraandhydroxychloroquinetreatmentforrheumatoidarthritis
AT triciaamissallmdphd ulcerativenecrobiosislipoidicainthesettingofantitumornecrosisfactoraandhydroxychloroquinetreatmentforrheumatoidarthritis
_version_ 1725177313358774272

Similar Items